Stay updated on BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial
Sign up to get notified when there's something new on the BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FH3n2cQdSWEHVdg9tTcOzGtkkAwI.uncropped.jpg&w=3840&q=75)
Latest updates to the BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial page
- ChecktodayChange DetectedThe website has removed estimated timestamps for the first and last posted results, now displaying only the actual timestamps.SummaryDifference0.1%
- CheckyesterdayChange DetectedA new study has been added to assess the efficacy and safety of BIO89-100 (pegozafermin) in participants with severe hypertriglyceridemia, with results posted on July 25, 2024, while the previous study from July 27, 2022, has been removed.SummaryDifference45%
- Check2 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 48 locations and has been updated from revision v2.9.7 to v2.10.0.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial page.